EGFR and lung adenocarcinoma: When based on patients, EGFR mutations in the MPLA group were more common in women without a smoking history than in the wild-type EGFR group, similar to the clinical characteristics of patients with EGFR mutations in single primary lung adenocarcinoma (SPLA) [26–28].